Camosunate Junior is an antimalarial medication formulated for children aged 7 to 13 years. It contains a combination of artemisinin-based compounds, commonly used to treat and prevent malaria, especially in regions with chloroquine-resistant strains of the parasite.
Precautions:
Administer as prescribed by a healthcare provider. Ensure the child completes the full course of treatment. Consult a healthcare provider before use if the child has any underlying health conditions or is taking other medications.
Side Effects:
If severe symptoms occur, seek medical attention immediately.